Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letibotulinum Toxin A Diffusion and Efficacy for Forehead Wrinkles
NCT07072806Phase 4Completed
- Sponsor
- Yonsei University
- Start
- Jun 2022
- Primary completion
- Aug 2022
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of letibotulinumtoxinA in forehead wrinkles, sponsored by Yonsei University. Started Jun 2022; status: completed.
02
Drugs
letibotulinumtoxinA
03
Conditions
forehead wrinkles
Beyond the preview
Go deeper on NCT07072806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07072806.